This investment supports the renewal of the CIHR Canadian HIV Trials Network (CTN). CTN formed in 1990 and has led in research for HIV/AIDS in Canada to generate knowledge on prevention, treatment, management and a cure for HIV/AIDS and other sexually transmitted blood-borne infections.
Dr. Melanie Murray of Oak Tree clinic was part of a panel at the event to speak to the importance of the funding as an investigator for CTN.
“Globally, women represent over 50 per cent of persons living with HIV and in Canada, these women have a seven year shorter life expectancy than their male counterparts,” said Dr. Murray. “Yet, women living with HIV remain understudied. CTN will provide us with a platform to research the factors that affect women and young women specifically to determine how we can better care for them.”
According to the Canadian Foundation for AIDS Research, there are more than 63,000 people in Canada living with HIV and 2,165 people become newly infected each year. This funding will support CTN’s collaborative work with national and international networks and partners for HIV prevention and to increase access to life-saving treatments for marginalized populations.
Learn more about CIHR Canadian HIV Trials Network.